会员体验
专利管家（专利管理）
工作空间（专利管理）
风险监控（情报监控）
数据分析（专利分析）
侵权分析（诉讼无效）
联系我们
交流群
官方交流：
QQ群： 891211   
微信请扫码    >>>
现在联系顾问~
下载
著录项
PDF全文
热词
    • 6. 发明专利
      HU9902707A2 INHIBITORS OF INTERLEUKIN-1BETA CONVERTING ENZYME 未知
    • INHIBITORS OF INTERLEUKIN-1BETA CONVERTING ENZYME
    • HU9902707A2
    • 1999-11-29
    • HU9902707
    • 1996-12-20
    • VERTEX PHARMA
    • BATCHELOR MARK J , BEBBINGTON DAVID , BEMIS GUY W , FRIDMAN WOLF HERMAN , GILLESPIE ROGER J , GOLEC JULIAN MARIAN CHARLES , GU YONG , LAUFFER DAVID J , LIVINGSTON DAVID J , MATHARU SAROOP SINGH , MULLICAN MICHAEL D , MURCKO MARK A , MURDOCH ROBERT , NYCE PHILIP L , ROBIDOUX ANDREA L C , SU MICHAEL , WANNAMAKER M WOODS , WILSON KEITH P , ZELLE ROBERT E
    • A61K31/55 , A61K38/08 , C07D487/04 , C07D498/04 , C07K5/02
    • Amine derivatives of formula (~a), (I) and (II) are new: X1 = CH; g = 0 or 1; J = H, OH or F; provided that when one J = OH the other is H; m = 0-2; T = OH, COCO2H, COOH or a bio-isosteric replacement for COOH; R1 = a group of formula (w), in which any ring may be optionally C-substituted by Q1, N-substituted by R5 or substituted by O,OH,COOH or halo, and any saturated ring may be unsaturated at 1 or 2 bonds; ring A = benzo, pyrido, thieno, pyrrolo, furano, thiazolo, isothiazolo, oxazolo, isoxazolo, pyrimidino, imidazolo, cyclopentyl or cyclohexyl; R3 = CN, CH=CHR9, CH=NOR9, (CH2)1-3T1R9, CJ2R9, COR13 or COCONR5R10; R4 = H, Ar1, R9, T1R9 or (CH2)1- 3T1R9; T1 = CH=CH, O, S, SO, NR10, NR10CO, CO, OCO, COO, CONR10, OCONR10, NR10COO, NR10COONR10, SO2NR10, NR10SO2 or NR10SO2NR10; R5 = H, Ar1, COAr1, SO2Ar1, CONH2, SO2NH2, R9, COR9, COOR9, SO2R9, CONR10Ar1, SO2Ar1R10, CONR9R10 or SO2NR9R10; R6 = H, AR1, R9, (CH2)1-3 T1R9 or an ~a-amino acid residue; R9 = 1-6C alkyl optionally substituted by OH, F or O and optionally substituted by 1 or 2 Ar1; R10 = H or 1-6C alkyl; R13 = Ar2, R4 or NR5OH; Ar1 = 6, 10, 12 or 14C mono, bi or tri cyclic aryl, 3-15C optionally benzo fused mono-, bi- or tri-cycloalkyl or 3-15C mono-, bi- or tri-cyclic heterocyclyl containing one or more O, S, N, SO, SO2 or NH, optionally containing one or more double bonds and comprising one or more aromatic rings, all optionally substituted by NH2, CO2H, Cl, F, Br, I, NO2, CN, O, OH, 1-3C perfluoroalkyl, OCH2O or Q1; Ar2 = a group of formula (hh), (ii), (jj) or (kk) all optionally substituted by Q1 and/or Q2; Q1 = Ar1, OAr1, R9, T1R9 or (CH2)1-3T1R9; Q2 = OH, NH2, COOH, Cl, Br, I, NO2, CN, CF3, or OCH2O; provided that when Ar1 is substituted with a Q1 group which comprises Ar1 the additional Ar1 are not substituted by Q1; X = N or CH; X2 = O, CH2, NH, S, SO or SO2; Y = O, S or NH; provided that when g = 0, J= H, m =1, T =CO2H, X2 = O, R5 =benzyloxycarbonyl, and ring A = benzo then R3 cannot be COR13 when R13 = CH2OAr1 and Ar1 = 1-phenyl-3-trifluoromethylpyrazol-5-yl optionally ring substituted by Cl, or when R13 = CH2OCOAr1 and Ar1 = 2,6-dichlorophenyl; R1a = a group of formula (e10) - (e12), (w2), (y1), (y2) or (z): R2 = a group of formula (a) or (b): m1 = 1 or 2; R51 = COR101, COOR91, CONR101R101, SO2R91, COCH2OR91, COCOR101, R91, H or COCOOR101; X5 = CH or N; Y2 = H2 or O; X7 = NR8 or O; R6 = H or Me; R8 = COR101, COOR91, CONHR101, SO2R91, SO2NHR101, COCH2OR101, COCOR101, COCH2NR101R101, COCH2COOR91, COCH2COR91, H or COCOOR101; R91 = H or optionally unsaturated 1-6C alkyl optionally substituted by Ar3; R101 = H, Ar3, 3-6C cycloalkyl or optionally unsaturated 1-6C alkyl optionally substituted by Ar3; R13 = H, Ar3 or 1-6C alkyl optionally substituted by Ar3, CONH2, OR5, OH, OR91 or COOH; or in (II) R13 is optionally NHOH (sic); R5a = R91, COR91 or CONHR91; or R51+R51 = 4-8 membered carbocyclyl or heterocyclyl containing O, S or NH; R21 = H or 1-6C alkyl; Ar3, Ar4 = 6, 10, 12 or 14C mono-, bi- or tri-cyclic aryl, 3-15C optionally benzo-fused mono-, bi- or tri- cycloalkyl or 3-15C mono, bi or tri cyclic heterocyclyl containing one or more O, S, N, SO, SO2 or NH, optionally containing one or more double bonds and comprising one or more aromatic rings, all optionally substituted by Q11; Q11 = NH2, CO2H, Cl, F, Br, I, NO2, CN, O, OH, 1-3C perfluoroalkyl, R51, OR51, NHR51, OR91, NHR91 COR101 or OCH2O; provided that when Ar3 is substituted with a Q11 group which comprises Ar3 the additional Ar3 are not substituted by Q11; R31 = CN, CHO, COCH2T1R11, COCH2F, C=NOR91 or COAr21; T1 = O, S, SO or SO2; R11 = Ar4, (CH2)1-3Ar4, H or COAr4; Ar21 = A group of formula (hh') or (ii') both optionally substituted by Q11 or phenyl optionally substituted by Q11; Y' = O or S; provided that in (II) when R1a = (e10) then X5 = N. Also claimed are (i) a further 13 new classes of compound, 2 analogous to (I) e.g. in which R1a = a group (w2) and R5 is broader; and 11 analogous to (II) e.g. R1a = a group (e10) and X5 = CH; and (ii) a process for preparing a N-acylamino
    • 基本信息 添加关注 加入工作空间 PDF全文 PDF下载 全文下载 相似专利 双屏查看 权利要求书 说明书全文 Espacenet 法律信息 同族专利 专利引用
每页展示10个专利
每页展示10个专利
每页展示20个专利
每页展示50个专利
每页展示100个专利

IPRDB

最新中国发明专利 最新美国发明专利 技术领域 专利库 专利分类库 国际专利分类库

热门服务

会员版试用 API 数据接口 找代理 知嘟嘟专利交易 排行榜 大学排行榜 专利百科

关于我们

平台介绍 战略合作 网站地图

友情链接

知嘟嘟专利交易 国家知识产权局 中国商标网

联系方式


©2019-2023 上海吉码数字技术有限公司 版权所有，并保留所有权利 沪ICP备20016256号-6 沪公网安备31011702005475号